| PERIOD ENDING | 31-Dec-02 | 31-Dec-01 | 31-Dec-00 | | Total Revenue | 3,506 | 3,803 | 1,803 | | Cost of Revenue |
-
|
-
|
-
| | | Gross Profit | 3,506 | 3,803 | 1,803 | | | Operating Expenses | | Research Development | 1,387 | 965 | 589 | | Selling General and Administrative | 1,925 | 1,654 | 1,002 | | Non Recurring | 555 |
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (361) | 1,184 | 212 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| | Earnings Before Interest And Taxes | (361) | 1,184 | 212 | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (361) | 1,184 | 212 | | Income Tax Expense | 154 | 473 | 79 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (514) | 710 | 134 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (514) | 710 | 134 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($514) | $710 | $134 |
|
0.31% Nasdaq 
0.05%
Income Statement
